Literature DB >> 19933290

Prevalence and determinants of left ventricular systolic dyssynchrony in patients with normal ejection fraction received right ventricular apical pacing: a real-time three-dimensional echocardiographic study.

Fang Fang1, Joseph Yat-Sun Chan, Gabriel Wai-Kwok Yip, Jun-Min Xie, Qing Zhang, Jeffrey Wing-Hong Fung, Yat-Yin Lam, Cheuk-Man Yu.   

Abstract

AIMS: Right ventricular apical (RVA) pacing may induce mechanical dyssynchrony. However, its impact on patients with normal ejection fraction (EF) is not fully understood. This study examined the prevalence and predictors of RVA pacing-induced systolic dyssynchrony by real-time three-dimensional echocardiography (RT3DE), and evaluated its impact on left ventricular (LV) function. METHODS AND
RESULTS: Ninety-three patients with sinus node dysfunction and normal EF (>50%) received RVA-based dual-chamber pacing were assessed by RT3DE during RVA pacing (V-pace) and intrinsic conduction (V-sense). Systolic dyssynchrony was evaluated using the standard deviation of the time to minimal regional volume of 16 LV segments (Tmsv-16SD), and a cutoff value of 16 ms was determined from 93 normal controls. Systolic dyssynchrony was induced in 49.5% of patients at V-pace with significant increase in LV end-systolic volume (LVESV), decrease in EF, and worsening of Tmsv-16SD (all P < 0.001). Furthermore, patients who developed dyssynchrony had larger LVESV (P < 0.001), lower EF (P < 0.001) at V-pace mode, and higher cumulative percentage of RVA pacing in the past 6 months (P < 0.001) than those without systolic dyssynchrony. In multivariate logistic regression analysis, independent predictors of developing LV systolic dyssynchrony during V-pace included a low normal EF at V-sense, pre-existing LV hypertrophy, and cumulative RVA pacing >40% in the past 6 months.
CONCLUSION: For patients with preserved EF received RVA pacing, half of them would develop systolic dyssynchrony which was associated with EF deterioration and LV enlargement. A low normal EF, a high cumulative percentage of RVA pacing, and pre-existing LV hypertrophy were predictors of developing dyssynchrony.

Entities:  

Mesh:

Year:  2009        PMID: 19933290     DOI: 10.1093/ejechocard/jep171

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  7 in total

Review 1.  Right ventricular pacing, mechanical dyssynchrony, and heart failure.

Authors:  Alan J Bank; Ryan M Gage; Kevin V Burns
Journal:  J Cardiovasc Transl Res       Date:  2011-12-22       Impact factor: 4.132

2.  Can cardiac resynchronization therapy cause harm?

Authors:  John E Sanderson; Cheuk-Man Yu
Journal:  Eur Heart J       Date:  2012-01-31       Impact factor: 29.983

3.  Cardiac Resynchronisation Therapy and Heart Failure: Persepctive from 5P Medicine.

Authors:  Fang Fang; Zhou Yu Jie; Luo Xiu Xia; Liu Ming; Ma Zhan; Gan Shu Fen; Yu Cheuk-Man
Journal:  Card Fail Rev       Date:  2015-04

Review 4.  Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.

Authors:  Fozia Z Ahmed; Rajdeep S Khattar; Amir M Zaidi; Ludwig Neyses; Delvac Oceandy; Mamas Mamas
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

5.  The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart.

Authors:  Andreas A Werdich; Anna Brzezinski; Darwin Jeyaraj; M Khaled Sabeh; Eckhard Ficker; Xiaoping Wan; Brian M McDermott; Calum A Macrae; David S Rosenbaum
Journal:  Prog Biophys Mol Biol       Date:  2012-07-23       Impact factor: 3.667

6.  Early Right Ventricular Apical Pacing-Induced Gene Expression Alterations Are Associated with Deterioration of Left Ventricular Systolic Function.

Authors:  Haiyan Xu; Xiongwei Xie; Jiangjin Li; Yuanyuan Zhang; Changsong Xu; Jing Yang
Journal:  Dis Markers       Date:  2017-08-08       Impact factor: 3.434

Review 7.  Chronic Right Ventricular Pacing in the Heart Failure Population.

Authors:  Justin Gould; Benjamin Sieniewicz; Bradley Porter; Baldeep Sidhu; Christopher A Rinaldi
Journal:  Curr Heart Fail Rep       Date:  2018-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.